Option Care Health (OPCH) PT Raised to $37 at TD Cowen

TD Cowen analyst Charles Rhyee raised the price target on Option Care Health (NASDAQ: OPCH) to $37.00 (from $27.00) while maintaining a Hold rating.

The analyst commented: 'After '26 prelim. guide was given in mid-Jan. (adj. EBITDA of $480-$505M), as well as sizing its anticipated Stelara gross profit impact ($25M-$35M), we expect questions regarding Stelara to start fading into the background, perhaps except estimated 1Q patient census. Instead, we expect focus shifting to drivers (market expansion, efficiencies through suites, etc.) of 10-13% adj. EBITDA growth OPCH expects ex-Stelara."

You May Also Be Interested In

• York Space Systems (YSS) PT Lowered to $15 at Jefferies
• Brookfield offers A$4.75/sh for Reliance Worldwide - Bloomberg
• argenx SE (ARGX) PT Raised to $1,095 at Truist Securities